Taro Receives Approval for Ketoconazole
Selected Abstract
Taro Receives Approval for Ketoconazole Cream, 2% ANDA; Amiodarone Tablets, 100 mg and 400 mg ANDA also Approved.
Business Editors/Health/Medical Writers HAWTHORNE, N.YBUSINESS WIREDec. 19, 2002 Taro Pharmaceutical Industries Ltd. (Nasdaq/NMS: TARO) reported today that the Company has received approval from the U.S. Food and Drug Administration ( FDA ) for its Abbreviated New Drug Application ( ANDA ) for ... December 19, 2002; Business Wire
Read the full article with a free-trial membership at HighBeam Research
Related Articles 1.
Taro Receives Approval for Ketoconazole Cream, 2% ANDA; Amiodarone Tablets, 100 mg and 400 mg ANDA also Approved.
|
